Apixaban for treatment of embolic stroke of undetermined source (ATTICUS randomized trial): Rationale and study design
2017 | journal article. A publication with affiliation to the University of Göttingen.
Jump to: Cite & Linked | Documents & Media | Details | Version history
Cite this publication
Apixaban for treatment of embolic stroke of undetermined source (ATTICUS randomized trial): Rationale and study design
Geisler, T.; Poli, S.; Meisner, C.; Schreieck, J.; Zuern, C. S; Nägele, T. & Brachmann, J. et al. (2017)
International Journal of Stroke, 12(9) pp. 985-990. DOI: https://doi.org/10.1177/1747493016681019
Documents & Media
Details
- Authors
- Geisler, Tobias; Poli, Sven; Meisner, Christoph; Schreieck, Juergen; Zuern, Christine S; Nägele, Thomas; Brachmann, Johannes; Jung, Werner; Gahn, Georg; Schmid, Elisabeth; Bäezner, Hansjörg; Keller, Timea; Petzold, Gabor C; Schrickel, Jan-Wilko; Liman, Jan ; Wachter, Rolf ; Schön, Frauke; Schabet, Martin; Lindner, Alfred; Ludolph, Albert C; Kimmig, Hubert; Jander, Sebastian; Schlegel, Uwe; Gawaz, Meinrad; Ziemann, Ulf
- Issue Date
- 2017
- Journal
- International Journal of Stroke
- ISSN
- 1747-4930
- eISSN
- 1747-4949
- Language
- English
